“Air Force intelligence components do not engage in experimentation involving human subjects for intelligence purposes,” a new Air Force Instruction (pdf) states categorically.
Except for the exceptions.
“Any exception would require approval by the Secretary or Under Secretary of the Air Force and would be undertaken only with the informed consent of the subject and in accordance with procedures established by AF/SG to safeguard the welfare of subjects.”
The new Instruction presents a generally scrupulous account of the regulatory framework within which Air Force intelligence operates. It addresses domestic search and surveillance, imagery collection and dissemination, mail covers, and other intelligence activities.
See Air Force Instruction 14-104, “Oversight of Intelligence Activities,” 16 April 2007.
Some other noteworthy new Air Force Instructions include these (both pdf):
AFI 10-2604, “Disease Containment Planning Guidance,” 6 April 2007.
AFI 40-201, “Managing Radioactive Materials in the U.S. Air Force,” 13 April 2007.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.